vs
CENTRAL PACIFIC FINANCIAL CORP（CPF）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
CENTRAL PACIFIC FINANCIAL CORP的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍（$72.9M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 28.4%，领先355.6%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 6.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.7%）
中太平洋金融公司旗下核心业务主体中太平洋银行是一家扎根美国夏威夷州的区域性商业银行，在全州范围内布局营业网点，主要为当地个人及各类企业客户提供多元化商业金融服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CPF vs RIGL — 直观对比
营收规模更大
CPF
是对方的1.0倍
$69.8M
营收增速更快
RIGL
高出15.2%
6.0%
净利率更高
RIGL
高出355.6%
28.4%
两年增速更快
RIGL
近两年复合增速
6.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $72.9M | $69.8M |
| 净利润 | $20.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 28.4% | 384.0% |
| 营收同比 | 6.0% | 21.2% |
| 净利润同比 | 16.7% | 1769.2% |
| 每股收益（稀释后） | $0.78 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPFRIGL
| Q1 26 | $72.9M | — | ||
| Q4 25 | $76.3M | $69.8M | ||
| Q3 25 | $74.8M | $69.5M | ||
| Q2 25 | $72.8M | $101.7M | ||
| Q1 25 | $68.8M | $53.3M | ||
| Q4 24 | $58.4M | $57.6M | ||
| Q3 24 | $66.6M | $55.3M | ||
| Q2 24 | $64.0M | $36.8M |
净利润CPFRIGL
| Q1 26 | $20.7M | — | ||
| Q4 25 | $22.9M | $268.1M | ||
| Q3 25 | $18.6M | $27.9M | ||
| Q2 25 | $18.3M | $59.6M | ||
| Q1 25 | $17.8M | $11.4M | ||
| Q4 24 | $11.3M | $14.3M | ||
| Q3 24 | $13.3M | $12.4M | ||
| Q2 24 | $15.8M | $-1.0M |
毛利率CPFRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率CPFRIGL
| Q1 26 | — | — | ||
| Q4 25 | 37.0% | 33.2% | ||
| Q3 25 | 31.6% | 40.9% | ||
| Q2 25 | 32.8% | 60.1% | ||
| Q1 25 | 32.8% | 23.9% | ||
| Q4 24 | 23.0% | 28.9% | ||
| Q3 24 | 25.6% | 25.4% | ||
| Q2 24 | 32.2% | 1.2% |
净利率CPFRIGL
| Q1 26 | 28.4% | — | ||
| Q4 25 | 30.0% | 384.0% | ||
| Q3 25 | 24.8% | 40.2% | ||
| Q2 25 | 25.1% | 58.6% | ||
| Q1 25 | 25.8% | 21.5% | ||
| Q4 24 | 19.4% | 24.9% | ||
| Q3 24 | 20.0% | 22.5% | ||
| Q2 24 | 24.7% | -2.8% |
每股收益（稀释后）CPFRIGL
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.85 | $14.11 | ||
| Q3 25 | $0.69 | $1.46 | ||
| Q2 25 | $0.67 | $3.28 | ||
| Q1 25 | $0.65 | $0.63 | ||
| Q4 24 | $0.42 | $0.82 | ||
| Q3 24 | $0.49 | $0.70 | ||
| Q2 24 | $0.58 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $76.5M | $52.5M |
| 股东权益账面价值 | $593.9M | $391.5M |
| 总资产 | $7.5B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.13× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CPFRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M |
总债务CPFRIGL
| Q1 26 | $76.5M | — | ||
| Q4 25 | $76.5M | $52.5M | ||
| Q3 25 | $131.5M | $60.0M | ||
| Q2 25 | $131.5M | $60.0M | ||
| Q1 25 | $131.4M | $60.0M | ||
| Q4 24 | $156.3M | $60.0M | ||
| Q3 24 | $156.3M | $60.0M | ||
| Q2 24 | $156.2M | $60.0M |
股东权益CPFRIGL
| Q1 26 | $593.9M | — | ||
| Q4 25 | $592.6M | $391.5M | ||
| Q3 25 | $588.1M | $117.6M | ||
| Q2 25 | $568.9M | $81.9M | ||
| Q1 25 | $557.4M | $18.6M | ||
| Q4 24 | $538.4M | $3.3M | ||
| Q3 24 | $543.7M | $-14.6M | ||
| Q2 24 | $518.6M | $-29.9M |
总资产CPFRIGL
| Q1 26 | $7.5B | — | ||
| Q4 25 | $7.4B | $513.6M | ||
| Q3 25 | $7.4B | $242.5M | ||
| Q2 25 | $7.4B | $206.7M | ||
| Q1 25 | $7.4B | $176.0M | ||
| Q4 24 | $7.5B | $164.0M | ||
| Q3 24 | $7.4B | $139.4M | ||
| Q2 24 | $7.4B | $128.4M |
负债/权益比CPFRIGL
| Q1 26 | 0.13× | — | ||
| Q4 25 | 0.13× | 0.13× | ||
| Q3 25 | 0.22× | 0.51× | ||
| Q2 25 | 0.23× | 0.73× | ||
| Q1 25 | 0.24× | 3.23× | ||
| Q4 24 | 0.29× | 18.25× | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.30× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CPFRIGL
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $22.0M | ||
| Q3 25 | $22.2M | $24.0M | ||
| Q2 25 | $34.3M | $30.5M | ||
| Q1 25 | $20.4M | $-893.0K | ||
| Q4 24 | $90.5M | $14.5M | ||
| Q3 24 | $21.3M | $21.7M | ||
| Q2 24 | $25.9M | $302.0K |
自由现金流CPFRIGL
| Q1 26 | — | — | ||
| Q4 25 | $92.3M | — | ||
| Q3 25 | $21.4M | — | ||
| Q2 25 | $32.3M | — | ||
| Q1 25 | $19.6M | — | ||
| Q4 24 | $75.4M | — | ||
| Q3 24 | $15.6M | — | ||
| Q2 24 | $21.3M | — |
自由现金流率CPFRIGL
| Q1 26 | — | — | ||
| Q4 25 | 121.0% | — | ||
| Q3 25 | 28.6% | — | ||
| Q2 25 | 44.3% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 129.2% | — | ||
| Q3 24 | 23.5% | — | ||
| Q2 24 | 33.2% | — |
资本支出强度CPFRIGL
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 25.8% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 7.3% | — |
现金转化率CPFRIGL
| Q1 26 | — | — | ||
| Q4 25 | 4.26× | 0.08× | ||
| Q3 25 | 1.20× | 0.86× | ||
| Q2 25 | 1.88× | 0.51× | ||
| Q1 25 | 1.15× | -0.08× | ||
| Q4 24 | 7.98× | 1.01× | ||
| Q3 24 | 1.60× | 1.75× | ||
| Q2 24 | 1.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
